type ii collagen ctx ii (Thermo Fisher)
Structured Review

Type Ii Collagen Ctx Ii, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/type ii collagen ctx ii/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
Images
1) Product Images from "Adenosine, lidocaine, and magnesium therapy augments joint tissue healing following experimental anterior cruciate ligament rupture and reconstruction"
Article Title: Adenosine, lidocaine, and magnesium therapy augments joint tissue healing following experimental anterior cruciate ligament rupture and reconstruction
Journal: Bone & Joint Research
doi: 10.1302/2046-3758.136.BJR-2023-0360.R1
Figure Legend Snippet: Study protocol schematic. ACL, anterior cruciate ligament; ALM, adenosine, lidocaine, and magnesium therapy; CTX-II, C-terminal cross-linked telopeptide of type II collagen; d, days; IA, intra-articular; IV, intravenous.
Techniques Used:
Figure Legend Snippet: Cartilage degenerative changes in male and female adenosine, lidocaine, and magnesium (ALM)-treated and Saline control animals, 28 days after anterior cruciate ligament reconstruction (ACLR) surgery. a) Postoperative urinary CTX-II levels peaked in the first postoperative week, and were higher in females than males. b) Osteoarthritis Research Society International (OARSI) scoring of medial articular cartilage surfaces, and c) representative safranin O/fast green-stained sections (magnification ×100) of medial femoral condyles (MFC, upper panels) and medial tibial plateau (MTP, lower panels). Minor proteoglycan loss (asterisk), and surface fibrillation (arrows) was evident, with no sex- or treatment-specific differences. d) Relative expression of cartilage extracellular matrix (ECM) components (collagen type 2, Col2a1; aggrecan, Acan), ECM remodelling enzymes (matrix metalloproteinase-13, MMP13; tissue inhibitor of matrix metalloproteinase 1, Timp1); and mediators of cell proliferation and activation (transforming growth factor β 1, Tgfb1; α smooth muscle actin, Acta2) in MFC cartilage. MMP13 levels were higher in males than females, with ALM dampening this response. In females, expression of Acan, Tgfb1, and Acta2 was increased in ALM-treated, than Saline control animals. e) Representative α-SMA-stained sections of MFC indicating the presence of positive-staining cells in the superficial and transitional zones (arrowheads) of ALM-treated animals. Data show medians and interquartile ranges. *p < 0.05, Kruskal–Wallis test.
Techniques Used: Saline, Control, Staining, Expressing, Activation Assay